European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending Merck & Co Inc (NYSE: MRK) Keytruda in melanoma...
Washington, D.C., May 19, 2022 (GLOBE NEWSWIRE) -- On May 19, the Embassy of the Kingdom of the Netherlands presented the 2022 Holland on the Hill Heineken Award to New...
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Consumer Services, Consumer Goods and Technology sectors propelled shares lower. At the close...
Deutsche Bank predicts the most aggressive monetary tightening since the 1980sCash-rich companies that have a history of paying dividends are one of the safest areas of the...
Merck came out with quarterly earnings of $2.14 per share.
Merck & Company (MRK) is not on the minds of many investors right now. The stock didn't have any major movements in the last year. The market is concerned because of the company's...
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 158.50 | 158.50 | 154.50 | +4.00 | +2.59% | 66.28K | London | |||
| 600.00 | 603.00 | 599.00 | +6.00 | +1.01% | 49.84K | London | |||
| 110.00 | 110.00 | 110.00 | +5.00 | +4.76% | 39.63K | London | |||
| 0.0225 | 0.0225 | 0.0225 | 0.0000 | 0.00% | 0.00 | London | |||
| 754.80 | 775.80 | 738.20 | +11.80 | +1.59% | 1.33M | London | |||
| 669.20 | 710.20 | 668.40 | -8.80 | -1.30% | 269.30K | London | |||
| 78.90 | 81.55 | 78.90 | -0.70 | -0.88% | 2.96M | London | |||
| 0.62 | 0.61 | 0.61 | +0.01 | +2.05% | 121.72K | London | |||
| 157.50 | 157.50 | 157.50 | +5.00 | +3.28% | 61.19K | London | |||
| 1,006.00 | 1,044.00 | 994.40 | +28.80 | +2.95% | 7.33M | London | |||
| 2,195.00 | 2,270.00 | 2,180.00 | -30.0 | -1.35% | 120.45K | London | |||
| 5.49 | 5.50 | 5.49 | 0.00 | 0.00% | 0.00 | London | |||
| 662.00 | 667.00 | 658.00 | +2.00 | +0.30% | 342.82K | London | |||
| 270.00 | 275.00 | 270.00 | 0.00 | 0.00% | 0.00 | London | |||
| 242.90 | 248.60 | 240.00 | +5.00 | +2.10% | 1.47M | London |